Like you, we're interested in revolutionary ideas. Technologies that are truly disruptive and meet large, unmet market needs. We're continually exploring new technology trends and have industry-specific teams dedicated to exploring these areas to gain a better understanding of the opportunities and challenges that lie ahead.
-
- Next-generation Biologics
- Advances in protein engineering addressing new target classes that untl now have been challenging for antibody-based approaches
- Targeted Drug Delivery
- Technologies for organ, tissue or cell-line specific delivery of small molecule or biologic therapeutics, including RNAi
- Immunomodulation
- Therapeutics for controlled activation or de-activation of immune system function, excluding cancer immunotherapy
- New Mechanisms for CNS Disease
- Disease-modifying approaches for major CNS disorders such as Alzheimer's and other forms of dementia, depression, epilepsy, Parkinson's
- Capital-Efficient Drug Development Strategies
- New strategies for streamlining drug development using biomarker-based patient stratification, offshoring of selected studies, drug repositioning
- Minimally Invasive Therapeutics
- Disruptive innovations that address important unmet clinical needs and which possess superior safety, efficacy and cost profiles relative to existing alternatives
- Therapy Enabling Technologies
- Novel innovations that provide significant clinical value by enabling clinicians and patients to address costly and clinically relevant inefficiencies in the delivery of care. These innovations may include diagnostics, imaging, robotics, drug delivery, and technology enabled services
- Digitization
- Solutions that leverage digitization platforms and proprietary algorithms to guide therapies, enhance workflows and improve accuracy of diagnostic efforts
